Chelators and metal complex stability for radiopharmaceutical applications

References

1. Bailey, D. L., Huum, J., Todd-Pokropek, A., Aswegen, A. V.: Nuclear medicine physics: a handbook for teachers and students, Vienna, International Atomic Energy Agency (IAEA) (2014).Search in Google Scholar

2. Deppen, S. A., Liu, E., Blume, J. D., Clanton, J., Shi, C., Jones-Jackson, L. B., Lakhani, V., Baum, R. P., Berlin, J., Smith, G. T.: Safety and efficacy of ⁶⁸Ga-DOTATATE PET/CT for diagnosis, staging, and treatment management of neuroendocrine tumors. J. Nucl. Med. 57, 708 (2016).10.2967/jnumed.115.163865Search in Google Scholar PubMed PubMed Central

3. Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H.: Phase 3 trial of ¹⁷⁷Lu-DOTATATE for midgut neuroendocrine tumors. N. Engl. J. Med. 376, 125 (2017).10.1056/NEJMoa1607427Search in Google Scholar PubMed PubMed Central

4. Cutler, C. S., Hennkens, H. M., Sisay, N., Huclier-Markai, S., Jurisson, S. S.: Radiometals for combined imaging and therapy. Chem. Rev. 113, 858 (2012).10.1021/cr3003104Search in Google Scholar PubMed

5. Boros, E., Packard, A. B.: Radioactive transition metals for imaging and therapy. Chem. Rev. 119(2), 870 (2018).10.1021/acs.chemrev.8b00281Search in Google Scholar PubMed

6. Kostelnik, T. I., Orvig, C.: Radioactive main group and rare earth metals for imaging and therapy. Chem. Rev. 119(2), 902 (2018).10.1021/acs.chemrev.8b00294Search in Google Scholar PubMed

7. Southworth, R., de Rosales, M. R. T., Meszaros, L. K., Ma, M. T., Mullen, G. E. D., Fruhwirth, G., Young, J. D., Imberti, C., Bagunya-Torres, J., Andreozzi, E., Blower, P. J.: Opportunities and challenges for metal chemistry in molecular imaging: from gamma camera imaging to PET and multimodality imaging. Adv. Inorg. Chem. 68, 1 (2016).10.1016/bs.adioch.2015.09.001Search in Google Scholar PubMed PubMed Central

8. Burke, B. P., Seemann, J., Archibald, S. J.: Advanced chelator design for metal complexes in imaging applications: radiopharmaceuticals, protein targeting, and conjugation. Adv. Inorg. Chem. 68, 301 (2016).10.1016/bs.adioch.2015.11.002Search in Google Scholar

9. Okarvi, S. M., Maecke, H. R.: Radiometallo-labeled peptides in tumor diagnosis and targeted radiotherapy. Adv. Inorg. Chem. 68, 341 (2016).10.1016/bs.adioch.2015.11.003Search in Google Scholar

10. Piramoon, M., Hosseinimehr, S. J.: The past, current studies and future of organometallic ^99mTc(CO)₃ labeled peptides and proteins. Curr. Pharm. Design 22, 4854 (2016).10.2174/1381612822666160623081838Search in Google Scholar PubMed

11. Zeglis, B. M., Houghton, J. L., Evans, M. J., Viola-Villegas, N., Lewis, J. S.: Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals. Inorg. Chem. 53, 1880 (2014).10.1021/ic401607zSearch in Google Scholar PubMed PubMed Central

12. Giblin, M. F., Wang, N., Hoffman, T. J., Jurisson, S. S., Quinn, T. P.: Design and characterization of α-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination. Proc. Natl. Acad. Sci. USA 95, 12814 (1998).10.1073/pnas.95.22.12814Search in Google Scholar PubMed PubMed Central

13. Chen, J., Cheng, Z., Hoffman, T. J., Jurisson, S. S., Quinn, T. P.: Melanoma-targeting properties of ^99mTechnetium-labeled cyclic α-melanocyte-stimulating hormone peptide analogues. Cancer Res. 60, 5649 (2000).Search in Google Scholar

14. O’Neil, J. P., Carlson, K. E., Anderson, C. J., Welch, M. J., Katzenellenbogen, J. A.: Progestin radiopharmaceuticals labeled with technetium and rhenium: synthesis, binding affinity, and in vivo distribution of a new progestin N₂S₂ – metal conjugate. Bioconjugate Chem. 5, 182 (1994).10.1021/bc00027a002Search in Google Scholar PubMed

15. Hom, R. K., Chi, D. Y., Katzenellenbogen, J. A.: Heterodimeric Bis(amino thiol) complexes of oxorhenium(V) that mimic the structure of steroid hormones. Synthesis and stereochemical issues. J. Org. Chem. 61, 2624 (1996).10.1021/jo951995kSearch in Google Scholar PubMed

16. Boonstra, M. C., De Geus, S. W., Prevoo, H. A., Hawinkels, L. J., Van De Velde, C. J., Kuppen, P. J., Vahrmeijer, A. L., Sier, C. F.: Selecting targets for tumor imaging: an overview of cancer-associated membrane proteins. Biomark. Cancer. 8, BIC. S38542 (2016).10.4137/BIC.S38542Search in Google Scholar PubMed PubMed Central

17. Notni, J., Wester, H. J.: A practical guide on the synthesis of metal chelates for molecular imaging and therapy by means of click chemistry. Chem. Eur. J. 22, 11500 (2016).10.1002/chem.201600928Search in Google Scholar PubMed

18. Altai, M., Membreno, R., Cook, B., Tolmachev, V., Zeglis, B. M.: Pretargeted imaging and therapy. J. Nucl. Med. 58, 1553 (2017).10.2967/jnumed.117.189944Search in Google Scholar PubMed PubMed Central

19. Wadas, T. J., Wong, E. H., Weisman, G. R., Anderson, C. J.: Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem. Rev. 110, 2858 (2010).10.1021/cr900325hSearch in Google Scholar PubMed PubMed Central

20. Weller, M., Overton, T., Rourke, J., Armstrong, F.: Inorganic Chemistry, 7th Ed., Oxford University Press, Oxford, UK (2018), p. 237.Search in Google Scholar

21. McMurry, J. E., Fay, R. C.: General Chemistry, Atoms First, 2nd Ed., Pearson Education, Inc., Upper Saddle River, NJ (2014), p. 511.Search in Google Scholar

22. Dearling, J. L. J., Voss, S. D., Dunning, P. Snay, E., Fahey, F., Smith, S. V., Huston, J. S., Meares, C. F., Treves, S. T., Packard, A. B.: Imaging cancer using PET – the effect of the bifunctional chelator on the biodistribution of a ⁶⁴Cu-labeled antibody. Nucl. Med. Biol. 38, 29 (2011).10.1016/j.nucmedbio.2010.07.003Search in Google Scholar PubMed PubMed Central

23. Anderson, C. J., Pajeau, T. S., Edwards, W. B., Sherman, E. L. C., Rogers, B. E., Welch, M. J.: In vitro and in vivo evaluation of copper-64-octreotide conjugates. J. Nucl. Med. 36, 2315 (1995).Search in Google Scholar

24. Rogers, B. E., Anderson, C. J., Connett, J. M., Guo, L. W., Edwards, W. B., Sherman, E. L. C., Zinn, K. R., Welch, M. J.: Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. Bioconjugate Chem. 7, 511 (1996).10.1021/bc9600372Search in Google Scholar PubMed

25. Fani, M., Del Pozzo, L., Abiraj, K., Mansi, R., Tamma, M. L., Cescato, R., Waser, B., Weber, W. A., Reubi, J. C., Maecke, H. R.: PET of somatostatin receptor-positive tumors using ⁶⁴Cu- and ⁶⁸Ga-somatostatin antagonists: the chelate makes the difference. J. Nucl. Med. 52(7), 1110 (2011).10.2967/jnumed.111.087999Search in Google Scholar PubMed

26. Papagiannopoulou, D.: Technetium-99m radiochemistry for pharmaceutical applications. J. Label. Compd. Radiopharm. 60, 502 (2017).10.1002/jlcr.3531Search in Google Scholar

27. Maecke, H. R., Riesen, A., Ritter, W.: The molecular structure of indium-DTPA. J. Nucl. Med. 30, 1235 (1989).Search in Google Scholar

28. Olsen, J. O., Pozderac, R. V., Hinkle, G., Hill, T., O’Dorisio, T. M., Schirmer, W. J., Ellison, E. C., O’Dorisio, M. S.: Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan). Semin. Nucl. Med. 25, 251 (1995).10.1016/S0001-2998(95)80014-XSearch in Google Scholar

29. Han, M., Partin, A. W.: Current clinical applications of the ¹¹¹In-capromab Pendetide Scan (ProstaScint^® Scan, Cyt-356). Rev. Urol. 3, 165 (2001).Search in Google Scholar

30. Ramogida, C. F., Orvig, C.: Tumour targeting with radiometals for diagnosis and therapy. Chem. Commun. (Camb.) 49, 4720 (2013).10.1039/c3cc41554fSearch in Google Scholar

31. Price, E. W., Orvig, C.: Matching chelators to radiometals for radiopharmaceuticals. Chem. Soc. Rev. 43, 260 (2014).10.1039/C3CS60304KSearch in Google Scholar

32. Hnatowich, D. J., Chinol, M., Siebecker, D. A., Gionet, M., Griffin, T., Doherty, P. W., Hunter, R., Kase, K. R.: Patient biodistribution of intraperitoneally administered yttrium-90-labeled antibody. J. Nucl. Med. 29, 1428 (1988).Search in Google Scholar

33. Brechbiel, M. W., Gansow, O. A.: Backbone-substituted DTPA ligands for Yttrium-90 radioimmunotherapy. Bioconjugate Chem. 2, 187 (1991).10.1021/bc00009a008Search in Google Scholar

34. Lattuada, L., Barge, A., Cravotto, G., Giovenzana, G. B., Tei, L.: The synthesis and application of polyamino polycarboxylic bifunctional chelating agents. Chem. Soc. Rev. 40, 3019 (2011).10.1039/c0cs00199fSearch in Google Scholar

35. Gansow, O. A., Top, L. E., Perentesis, P., Reynolds, J. C., Nelson, D. L., Waldmann, T. A.: Similarities and differences in ¹¹¹In and ⁹⁰Y labeled 1B4M-DTPA AntiTac monoclonal antibody distribution. J. Nucl. Med. 40, 268 (1999).Search in Google Scholar

36. Camera, L., Kinuya, S., Garmestani, K., Brechbiel, M. W., Wu, C. C., Pai, L. H., Mcmurry, T. J., Gansow, O. A., Pastan, I., Paik, C. H., Carrasquillo, J. A.: Comparative biodistribution of indium-labeled and yttrium-labeled B3 monoclonal-antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1b4m-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2b-DOTA). Eur. J. Nucl. Med. 21, 640 (1994).10.1007/BF00285586Search in Google Scholar

37. Wiseman, G. A., White, C. A., Stabin, M., Dunn, W. L., Erwin, W., Dahlbom, M., Raubitschek, A., Karvelis, K., Schultheiss, T., Witzig, T. E., Belanger, R., Spies, S., Silverman, D. H., Berlfein, J. R., Ding, E., Grillo-Lopez, A. J.: Phase I/II ⁹⁰Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin’s lymphoma. Eur. J. Nucl. Med. Mol. Imaging 27, 766 (2000).10.1007/s002590000276Search in Google Scholar

38. Wiseman, G. A., White, C. A., Sparks, R. B., Erwin, W. D., Podoloff, D. A., Lamonica, D., Bartlett, N. L., Parker, J. A., Dunn, W. L., Spies, S. M., Belanger, R., Witzig, T. E., Leigh, B. R.: Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin (TM) radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin’s lymphoma. Crit. Rev. Oncol. Hematol. 39, 181 (2001).10.1016/S1040-8428(01)00107-XSearch in Google Scholar

39. Camera, L., Kinuya, S., Garmestani, K., Wu, C., Brechbiel, M. W., Pai, L. H., McMurry, T. J., Gansow, O. A., Pastan, I., Paik, C. H., et al.: Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies. J. Nucl. Med. 35, 882 (1994).Search in Google Scholar

40. Brechbiel, M. W., Gansow, O. A.: Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepenta-acetic acids for labelling of monoclonal antibodies with the Bismuth-212 α-particle emitter. J. Chem. Soc., Perkin Trans. 1, 1173 (1992).10.1039/P19920001173Search in Google Scholar

41. Milenic, D. E., Roselli, M., Mirzadeh, S., Pippin, C. G., Gansow, O. A., Colcher, D., Brechbiel, M. W., Schlom, J.: In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates. Cancer Biother. Radiopharm. 16, 133 (2001).10.1089/108497801300189227Search in Google Scholar

42. Wei, L., Zhang, X., Gallazzi, F., Miao, Y., Jin, X., Brechbiel, M. W., Xu, H., Clifford, T., Welch, M. J., Lewis, J. S.: Melanoma imaging using ¹¹¹In, ⁸⁶Y and ⁶⁸Ga-labeled CHX-A″-Re(Arg¹¹)CCMSH. Nucl. Med. Biol. 36, 345 (2009).10.1016/j.nucmedbio.2009.01.007Search in Google Scholar

43. Blend, M. J., Stastny, J. J., Swanson, S. M., Brechbiel, M. W.: Labeling anti-HER2/neu monoclonal antibodies with ¹¹¹In and ⁹⁰Y using a bifunctional DTPA chelating agent. Cancer Biother. Radiopharm. 18, 355 (2003).10.1089/108497803322285107Search in Google Scholar

44. Baur, B., Solbach, C., Andreolli, E., Winter, G., Machulla, H.-J., Reske, S. N.: Synthesis, radiolabelling and in vitro characterization of the gallium-68-, yttrium-90-and lutetium-177-labelled PSMA Ligand, CHX-A″-DTPA-DUPA-Pep. Pharmaceuticals 7, 517 (2014).10.3390/ph7050517Search in Google Scholar

45. Milenic, D. E., Garmestani, K., Chappell, L. L., Dadachova, E., Yordanov, A., Ma, D., Schlom, J., Brechbiel, M. W.: In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with ¹⁷⁷Lu for radioimmunotherapeutic applications. Nucl. Med. Biol. 29, 431 (2002).10.1016/S0969-8051(02)00294-9Search in Google Scholar

46. Hens, M., Vaidyanathan, G., Zhao, X. G., Bigner, D. D., Zalutsky, M. R.: Anti-EGFRvIII monoclonal antibody armed with ¹⁷⁷Lu: in vivo comparison of macrocyclic and acyclic ligands. Nucl. Med. Biol. 37, 741 (2010).10.1016/j.nucmedbio.2010.04.020Search in Google Scholar

47. Pandya, D. N., Bhatt, N., Yuan, H., Day, C. S., Ehrmann, B. M., Wright, M., Bierbach, U., Wadas, T. J.: Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development. Chem. Sci. 8, 2309 (2017).10.1039/C6SC04128KSearch in Google Scholar

48. van de Watering, F. C., Rijpkema, M., Perk, L., Brinkmann, U., Oyen, W. J., Boerman, O. C.: Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients. Biomed. Res. Int. 2014, 203601 (2014).10.1155/2014/203601Search in Google Scholar

49. Deri, M. A., Zeglis, B. M., Francesconi, L. C., Lewis, J. S.: PET imaging with ⁸⁹Zr: from radiochemistry to the clinic. Nucl. Med. Biol. 40, 3 (2013).10.1016/j.nucmedbio.2012.08.004Search in Google Scholar

50. Eisenwiener, K. P., Powell, P., Macke, H. R.: A convenient synthesis of novel bifunctional prochelators for coupling to bioactive peptides for radiometal labelling. Bioorg. Med. Chem. Lett. 10, 2133 (2000).10.1016/S0960-894X(00)00413-3Search in Google Scholar

51. Chappell, L. L., Dadachova, E., Milenic, D. E., Garmestani, K., Wu, C., Brechbiel, M. W.: Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes ²⁰³Pb and ²¹²Pb. Nucl. Med. Biol. 27, 93 (2000).10.1016/S0969-8051(99)00086-4Search in Google Scholar

52. Meredith, R., Torgue, J., Shen, S., Fisher, D. R., Banaga, E., Bunch, P., Morgan, D., Fan, J., Straughn, J. M., Jr.: Dose escalation and dosimetry of first-in-human alpha radioimmunotherapy with ²¹²Pb-TCMC-trastuzumab. J. Nucl. Med. 55, 1636 (2014).10.2967/jnumed.114.143842Search in Google Scholar PubMed PubMed Central

53. Meredith, R. F., Torgue, J., Azure, M. T., Shen, S., Saddekni, S., Banaga, E., Carlise, R., Bunch, P., Yoder, D., Alvarez, R.: Pharmacokinetics and imaging of ²¹²Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients. Cancer Biother. Radiopharm. 29, 12 (2014).10.1089/cbr.2013.1531Search in Google Scholar PubMed PubMed Central

54. Correia, J. D., Paulo, A., Raposinho, P. D., Santos, I.: Radiometallated peptides for molecular imaging and targeted therapy. Dalton Trans. 40, 6144 (2011).10.1039/c0dt01599gSearch in Google Scholar PubMed

55. Velikyan, I., Maecke, H., Langstrom, B.: Convenient preparation of ⁶⁸Ga-based PET-radiopharmaceuticals at room temperature. Bioconjugate Chem. 19, 569 (2008).10.1021/bc700341xSearch in Google Scholar PubMed

56. Tsionou, M. I., Knapp, C. E., Foley, C. A., Munteanu, C. R., Cakebread, A., Imberti, C., Eykyn, T. R., Young, J. D., Paterson, B. M., Blower, P. J., Ma, M. T.: Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling. RSC Adv. 7, 49586 (2017).10.1039/C7RA09076ESearch in Google Scholar PubMed PubMed Central

57. Maheshwari, V., Dearling, J. L., Treves, S. T., Packard, A. B.: Measurement of the rate of copper (II) exchange for ⁶⁴Cu complexes of bifunctional chelators. Inorg. Chim. Acta 393, 318 (2012).10.1016/j.ica.2012.07.012Search in Google Scholar

58. Zhang, Y., Hong, H., Engle, J. W., Bean, J., Yang, Y., Leigh, B. R., Barnhart, T. E., Cai, W.: Positron emission tomography imaging of CD105 expression with a ⁶⁴Cu-labeled monoclonal antibody: NOTA is superior to DOTA. PLoS One 6, e28005 (2011).10.1371/journal.pone.0028005Search in Google Scholar PubMed PubMed Central

59. Kubicek, V., Bohmova, Z., Sevcikova, R., Vanek, J., Lubal, P., Polakova, Z., Michalicova, R., Kotek, J., Hermann, P.: NOTA complexes with copper(II) and divalent metal ions: kinetic and thermodynamic studies. Inorg. Chem. 57, 3061 (2018).10.1021/acs.inorgchem.7b02929Search in Google Scholar PubMed

60. André, J. P., Maecke, H. R., Zehnder, M., Macko, L., Akyel, K. G.: 1, 4, 7-Triazacyclononane-1-succinic acid-4, 7-diacetic acid (NODASA): a new bifunctional chelator for radio gallium-labelling of biomolecules. Chem. Commun. 1301 (1998).10.1039/a801294fSearch in Google Scholar

61. Dutta, J., Chinthakindi, P. K., Arvidsson, P. I., de la Torre, B. G., Kruger, H. G., Govender, T., Naicker, T., Albericio, F.: A Facile synthesis of NODASA-functionalized peptide. Synlett 27, 1685 (2016).10.1055/s-0035-1561970Search in Google Scholar

62. Eisenwiener, K. P., Prata, M. I., Buschmann, I., Zhang, H. W., Santos, A. C., Wenger, S., Reubi, J. C., Macke, H. R.: NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [^67/68Ga] and [¹¹¹In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors. Bioconjugate Chem. 13, 530 (2002).10.1021/bc010074fSearch in Google Scholar PubMed

63. Rylova, S. N., Stoykow, C., Del Pozzo, L., Abiraj, K., Tamma, M. L., Kiefer, Y., Fani, M., Maecke, H. R.: The somatostatin receptor 2 antagonist ⁶⁴Cu-NODAGA-JR11 outperforms ⁶⁴Cu-DOTA-TATE in a mouse xenograft model. PLoS One 13, e0195802 (2018).10.1371/journal.pone.0195802Search in Google Scholar PubMed PubMed Central

64. Ghosh, S. C., Pinkston, K. L., Robinson, H., Harvey, B. R., Wilganowski, N., Gore, K., Sevick-Muraca, E. M., Azhdarinia, A.: Comparison of DOTA and NODAGA as chelators for ⁶⁴Cu-labeled immunoconjugates. Nucl. Med. Biol. 42, 177 (2015).10.1016/j.nucmedbio.2014.09.009Search in Google Scholar PubMed

65. Chong, H. S., Song, H. A., Birch, N., Le, T., Lim, S., Ma, X.: Efficient synthesis and evaluation of bimodal ligand NETA. Bioorg. Med. Chem. Lett. 18, 3436 (2008).10.1016/j.bmcl.2008.03.084Search in Google Scholar PubMed

66. Chong, H. S., Garmestani, K., Ma, D. S., Milenic, D. E., Overstreet, T., Brechbiel, M. W.: Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics. J. Med. Chem. 45, 3458 (2002).10.1021/jm0200759Search in Google Scholar PubMed

67. Kang, C. S., Sun, X., Jia, F., Song, H. A., Chen, Y., Lewis, M., Chong, H. S.: Synthesis and preclinical evaluation of bifunctional ligands for improved chelation chemistry of ⁹⁰Y and ¹⁷⁷Lu for targeted radioimmunotherapy. Bioconjugate Chem. 23, 1775 (2012).10.1021/bc200696bSearch in Google Scholar PubMed PubMed Central

68. Kang, C. S., Chen, Y., Lee, H., Liu, D., Sun, X., Kweon, J., Lewis, M. R., Chong, H.-S.: Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using ⁹⁰Y or ¹⁷⁷Lu. Nucl. Med. Biol. 42, 242 (2015).10.1016/j.nucmedbio.2014.10.004Search in Google Scholar PubMed PubMed Central

69. Kang, C. S., Song, H. A., Milenic, D. E., Baidoo, K. E., Brechbiel, M. W., Chong, H.-S.: Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using ²¹²Bi and ²¹³Bi: radiolabeling, serum stability, and biodistribution and tumor uptake studies. Nucl. Med. Biol. 40, 600 (2013).10.1016/j.nucmedbio.2013.01.012Search in Google Scholar PubMed PubMed Central

70. Bass, L. A., Wang, M., Welch, M. J., Anderson, C. J.: In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjugate Chem. 11, 527 (2000).10.1021/bc990167lSearch in Google Scholar PubMed

71. Woodin, K. S., Heroux, K. J., Boswell, C. A., Wong, E. H., Weisman, G. R., Niu, W. J., Tomellini, S. A., Anderson, C. J., Zakharov, L. N., Rheingold, A. L.: Kinetic inertness and electrochemical behavior of copper(II) tetraazamacrocyclic complexes: possible implications for in vivo stability. Eur. J. Inorg. Chem. 2005, 4829 (2005).10.1002/ejic.200500579Search in Google Scholar

72. Boswell, C. A., Sun, X., Niu, W., Weisman, G. R., Wong, E. H., Rheingold, A. L., Anderson, C. J.: Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J. Med. Chem. 47, 1465 (2004).10.1021/jm030383mSearch in Google Scholar PubMed

73. Wong, E. H., Weisman, G. R., Hill, D. C., Reed, D. P., Rogers, M. E., Condon, J. S., Fagan, M. A., Calabrese, J. C., Lam, K. C., Guzei, I. A., Rheingold, A. L.: Synthesis and characterization of cross-bridged cyclams and pendant-armed derivatives and structural studies of their copper(II) complexes. J. Am. Chem. Soc. 122, 10561 (2000).10.1021/ja001295jSearch in Google Scholar

74. Camus, N., Halime, Z., Le Bris, N., Bernard, H., Platas-Iglesias, C., Tripier, R.: Full control of the regiospecific N-functionalization of C-functionalized cyclam bisaminal derivatives and application to the synthesis of their TETA, TE2A, and CB-TE2A analogues. J. Org. Chem. 79, 1885 (2014).10.1021/jo4028566Search in Google Scholar PubMed

75. Lewis, E. A., Boyle, R. W., Archibald, S. J.: Ultrastable complexes for in vivo use: a bifunctional chelator incorporating a cross-bridged macrocycle. Chem. Commun. (Camb.) 2212 (2004).10.1039/b406906dSearch in Google Scholar PubMed

76. Wadas, T. J., Anderson, C. J.: Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64. Nat. Protoc. 1, 3062 (2006).10.1038/nprot.2006.431Search in Google Scholar PubMed

77. Boros, E., Ferreira, C. L., Cawthray, J. F., Price, E. W., Patrick, B. O., Wester, D. W., Adam, M. J., Orvig, C.: Acyclic chelate with ideal properties for ⁶⁸Ga PET imaging agent elaboration. J. Am. Chem. Soc. 132, 15726 (2010).10.1021/ja106399hSearch in Google Scholar PubMed

78. Price, E. W., Cawthray, J. F., Bailey, G. A., Ferreira, C. L., Boros, E., Adam, M. J., Orvig, C.: H₄octapa: an acyclic chelator for ¹¹¹In radiopharmaceuticals. J. Am. Chem. Soc. 134, 8670 (2012).10.1021/ja3024725Search in Google Scholar PubMed

79. Price, E. W., Zeglis, B. M., Cawthray, J. F., Ramogida, C. F., Ramos, N., Lewis, J. S., Adam, M. J., Orvig, C.: H₄octapa-trastuzumab: versatile acyclic chelate system for ¹¹¹In and ¹⁷⁷Lu imaging and therapy. J. Am. Chem. Soc. 135, 12707 (2013).10.1021/ja4049493Search in Google Scholar PubMed PubMed Central

80. Ramogida, C. F., Cawthray, J. F., Boros, E., Ferreira, C. L., Patrick, B. O., Adam, M. J., Orvig, C.: H₂CHXdedpa and H₄CHXoctapa – chiral acyclic chelating ligands for ^67/68Ga and ¹¹¹In radiopharmaceuticals. Inorg. Chem. 54, 2017 (2015).10.1021/ic502942aSearch in Google Scholar PubMed

81. Cusnir, R., Imberti, C., Hider, R., Blower, P., Ma, M.: Hydroxypyridinone chelators: from iron scavenging to radiopharmaceuticals for PET imaging with gallium-68. Internat. J. Mol. Sci. 18(1), 116/1 (2017).10.3390/ijms18010116Search in Google Scholar PubMed PubMed Central

82. Ma, M. T., Cullinane, C., Waldeck, K., Roselt, P., Hicks, R. J., Blower, P. J.: Rapid kit-based ⁶⁸Ga-labelling and PET imaging with THP-Tyr³-octreotate: a preliminary comparison with DOTA-Tyr³-octreotate. EJNMMI Res. 5(1), 1 (2015).10.1186/s13550-015-0131-1Search in Google Scholar PubMed PubMed Central

83. Young, J. D., Abbate, V., Imberti, C., Meszaros, L. K., Ma, M. T., Terry, S. Y., Hider, R. C., Mullen, G. E., Blower, P. J.: ⁶⁸Ga-THP-PSMA: a PET imaging agent for prostate cancer offering rapid, room-temperature, 1-step kit-based radiolabeling. J. Nucl. Med. 58(8), 1270 (2017).10.2967/jnumed.117.191882Search in Google Scholar PubMed PubMed Central

84. Hofman, M. S., Eu, P., Jackson, P., Hong, E., Binns, D., Iravani, A., Murphy, D., Mitchell, C., Siva, S., Hicks, R. J.: Cold kit for prostate-specific membrane antigen (PSMA) PET imaging: phase I study of ⁶⁸Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer. J. Nucl. Med. 59(4), 625 (2018).10.2967/jnumed.117.199554Search in Google Scholar PubMed PubMed Central

85. Berry, D. J., Ma, Y., Ballinger, J. R., Tavaré, R., Koers, A., Sunassee, K., Zhou, T., Nawaz, S., Mullen, G. E., Hider, R. C.: Efficient bifunctional gallium-68 chelators for positron emission tomography: tris (hydroxypyridinone) ligands. Chem. Commun. 47(25), 7068 (2011).10.1039/c1cc12123eSearch in Google Scholar PubMed PubMed Central

86. Nawaz, S., Mullen, G. E., Sunassee, K., Bordoloi, J., Blower, P. J., Ballinger, J. R.: Simple, mild, one-step labelling of proteins with gallium-68 using a tris (hydroxypyridinone) bifunctional chelator: a ⁶⁸Ga-THP-scFv targeting the prostate-specific membrane antigen. EJNMMI Res. 7(1), 1 (2017).10.1186/s13550-017-0336-6Search in Google Scholar PubMed PubMed Central

87. Di Bartolo, N. M., Sargeson, A. M., Donlevy, T. M., Smith, S. V.: Synthesis of a new cage ligand, SarAr, and its complexation with selected transition metal ions for potential use in radioimaging. J. Chem. Soc. Dalton Trans. 2303 (2001).10.1039/b103242aSearch in Google Scholar

88. Voss, S. D., Smith, S. V., DiBartolo, N., McIntosh, L. J., Cyr, E. M., Bonab, A. A., Dearling, J. L. J., Carter, E. A., Fischman, A. J., Treves, S. T., Gillies, S. D., Sargeson, A. M., Huston, J. S., Packard, A. B.: Positron emission tomography (PET) imaging of neuroblastoma and melanoma with ⁶⁴Cu-SarAr immunoconjugates. Proc. Nat. Acad. Sci. USA 104, 17489 (2007).10.1073/pnas.0708436104Search in Google Scholar PubMed PubMed Central

89. Cooper, M. S., Ma, M. T., Sunassee, K., Shaw, K. P., Williams, J. D., Paul, R. L., Donnelly, P. S., Blower, P. J.: Comparison of ⁶⁴Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability. Bioconjugate Chem. 23, 1029 (2012).10.1021/bc300037wSearch in Google Scholar PubMed PubMed Central

90. Li, G., Wang, X., Zong, S., Wang, J., Conti, P. S., Chen, K.: MicroPET imaging of CD13 expression using a ⁶⁴Cu-labeled dimeric NGR peptide based on sarcophagine cage. Mol. Pharmaceutics 11, 3938 (2014).10.1021/mp500354xSearch in Google Scholar PubMed

91. Paterson, B. M., Alt, K., Jeffery, C. M., Price, R. I., Jagdale, S., Rigby, S., Williams, C. C., Peter, K., Hagemeyer, C. E., Donnelly, P. S.: Enzyme-mediated site-specific bioconjugation of metal complexes to proteins: sortase-mediated coupling of copper-64 to a single-chain antibody. Angew. Chem. Int. Ed. 53, 6115 (2014).10.1002/anie.201402613Search in Google Scholar PubMed

92. Dearling, J. L. J., Paterson, B. M., Akurathi, V., Betanzos-Lara, S., Treves, S. T., Voss, S. D., White, J. M., Huston, J. S., Smith, S. V., Donnelly, P. S., Packard, A. B.: The ionic charge of copper-64 complexes conjugated to an engineered antibody affects biodistribution. Bioconjugate Chem. 26, 707 (2015).10.1021/acs.bioconjchem.5b00049Search in Google Scholar PubMed

93. Liu, S., Huang, C.-W., Yap, L.-P., Park, R., Shan, H., Li, Z., Conti, P. S.: The efficient synthesis and biological evaluation of novel Bi-functionalized sarcophogine for ⁶⁴Cu radiopharmaceuticals. Theranostics 2(6), 589 (2012).10.7150/thno.4295Search in Google Scholar PubMed PubMed Central

94. Paterson, B. M., Buncic, G., McInnes, L. E., Roselt, P., Cullinane, C., Binns, D. S., Jeffery, C. M., Price, R. I., Hicks, R. J., Donnelly, P. S.: Bifunctional ⁶⁴Cu-labelled macrobicyclic cage amine isothiocyanates for immuno-positron emission tomography. Dalton Trans. 44, 4901 (2015).10.1039/C4DT02983FSearch in Google Scholar

95. Heskamp, S., Raave, R., Boerman, O., Rijpkema, M., Goncalves, V., Denat, F.: ⁸⁹Zr-immuno-positron emission tomography in oncology: state-of-the-art ⁸⁹Zr radiochemistry. Bioconjugate Chem. 28, 2211 (2017).10.1021/acs.bioconjchem.7b00325Search in Google Scholar PubMed PubMed Central

96. Holland, J. P., Divilov, V., Bander, N. H., Smith-Jones, P. M., Larson, S. M., Lewis, J. S.: ⁸⁹Zr-DFO-J591 for immunoPET imaging of prostate-specific membrane antigen (PSMA) expression in vivo. J. Nucl. Med. 51, 1293 (2010).10.2967/jnumed.110.076174Search in Google Scholar PubMed PubMed Central

97. Bhatt, N. B., Pandya, D. N., Wadas, T. J.: Recent advances in zirconium-89 chelator development. Molecules 23, 638 (2018).10.3390/molecules23030638Search in Google Scholar PubMed PubMed Central

98. Patra, M., Bauman, A., Mari, C., Fischer, C. A., Blacque, O., Haussinger, D., Gasser, G., Mindt, T. L.: An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes. Chem. Commun. (Camb.) 50, 11523 (2014).10.1039/C4CC05558FSearch in Google Scholar

99. Vugts, D. J., Klaver, C., Sewing, C., Poot, A. J., Adamzek, K., Huegli, S., Mari, C., Visser, G. W., Valverde, I. E., Gasser, G.: Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for ⁸⁹Zr-immuno-PET. Eur. J. Nucl. Med. Mol. Imaging 44, 286 (2017).10.1007/s00259-016-3499-xSearch in Google Scholar PubMed PubMed Central

100. Allott, L., Da Pieve, C., Meyers, J., Spinks, T., Ciobota, D. M., Kramer-Marek, G., Smith, G.: Evaluation of DFO-HOPO as an octadentate chelator for zirconium-89. Chem. Commun. (Camb.) 53, 8529 (2017).10.1039/C7CC03572ASearch in Google Scholar

101. Stradling, G. N., Gray, S. A., Moody, J. C., Hodgson, A., Raymond, K. N., Durbin, P. W., Rodgers, S. J., White, D. L., Turowski, P. N.: The Efficacy of DFO-HOPO, DTPA-Dx and DTPA for enhancing the excretion of plutonium and americium from the rat. Int. J. Radiat Biol. 59, 1269 (1991).10.1080/09553009114551131Search in Google Scholar PubMed

102. Deri, M. A., Ponnala, S., Zeglis, B. M., Pohl, G., Dannenberg, J., Lewis, J. S., Francesconi, L. C.: Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3, 4, 3-(LI-1, 2-HOPO). J. Med. Chem. 57, 4849 (2014).10.1021/jm500389bSearch in Google Scholar PubMed PubMed Central

103. Deri, M. A., Ponnala, S., Kozlowski, P., Burton-Pye, B. P., Cicek, H. T., Hu, C., Lewis, J. S., Francesconi, L. C.: p-SCN-Bn-HOPO: A superior bifunctional chelator for ⁸⁹Zr immunoPET. Bioconjugate Chem. 26, 2579 (2015).10.1021/acs.bioconjchem.5b00572Search in Google Scholar PubMed PubMed Central

104. Carroll, V., Demoin, D. W., Hoffman, T. J., Jurisson, S. S.: Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions. Radiochim. Acta. 100, 653 (2012).10.1524/ract.2012.1964Search in Google Scholar PubMed PubMed Central

105. Heeg, M. J., Jurisson, S. S.: The role of inorganic chemistry in the development of radiometal agents for cancer therapy. Acc. Chem. Res. 32, 1053 (1999).10.1021/ar980002cSearch in Google Scholar

106. Jürgens, S., Herrmann, W. A., Kühn, F. E.: Rhenium and technetium based radiopharmaceuticals: development and recent advances. J. Organomet. Chem. 751, 83 (2014).10.1016/j.jorganchem.2013.07.042Search in Google Scholar

107. Jurisson, S. S., Lydon, J. D.: Potential technetium small molecule radiopharmaceuticals. Chem. Rev. 99, 2205 (1999).10.1021/cr980435tSearch in Google Scholar PubMed

108. Schwochau, K.: Technetium radiopharmaceuticals – fundamentals, synthesis, structure, and development. Angew. Chem. Int. Ed. 33, 2258 (1994).10.1002/anie.199422581Search in Google Scholar

109. Mahmood, A., Jones, A. G., Technetium Radiopharmaceuticals. In: M. J. Welch, C. S. Redvanly (Eds.), Handbook of Radiopharmaceuticals, John Wiley & Sons, Ltd (2005), p. 323.10.1002/0470846380.ch10Search in Google Scholar

110. Volkert, W. A., Hoffman, T. J.: Therapeutic radiopharmaceuticals. Chem. Rev. 99, 2269 (1999).10.1021/cr9804386Search in Google Scholar PubMed

111. Liu, G., Hnatowich, D. J.: Labeling biomolecules with radiorhenium – a review of the bifunctional chelators. Anti-cancer Agents Med. Chem. 7, 367 (2007).10.2174/187152007780618144Search in Google Scholar PubMed PubMed Central

112. Bartholoma, M. D., Louie, A. S., Valliant, J. F., Zubieta, J.: Technetium and gallium derived radiopharmaceuticals: comparing and contrasting the chemistry of two important raidometals for the molecular imaging era. Chem. Rev. 110, 2903 (2010).10.1021/cr1000755Search in Google Scholar PubMed

113. Dilworth, J. R., Parrott, S. J.: The biomedical chemistry of technetium and rhenium. Chem. Soc. Rev. 27, 43 (1998).10.1039/a827043zSearch in Google Scholar

114. Blower, P. J.: A nuclear medicine chocholate box: the periodic table of nuclear medicine. Dalton Trans. 44, 4819 (2015).10.1039/C4DT02846ESearch in Google Scholar

115. Mei, L., Wang, Y., Chu, T.: ^99mTc/Re complexes bearing bisnitroimidazole or mononitroimidazole as potential bioreductive markers for tumor: synthesis, physicochemical characterization and biological evaluation. Eur. J. Med. Chem. 58, 50 (2012).10.1016/j.ejmech.2012.09.042Search in Google Scholar PubMed

116. Wang, X., Cui, M., Yu, P., Li, Z., Yang, Y., Jia, H., Liu, B.: Synthesis and biological evaluation of novel technetium-99m labeled phenylbenzoxazole derivatives as potential imaging probes for beta-amyloid plaques in brain. Bioorg. Med. Chem. Lett. 22, 4327 (2012).10.1016/j.bmcl.2012.05.010Search in Google Scholar PubMed

117. Sun, W., Chu, T.: In vivo click reaction between Tc-99m-labeled azadibenzocyclooctyne-MAMA and 2-nitroimidazole-azide for tumor hypoxia targeting. Bioorg. Med. Chem. Lett. 25, 4453 (2015).10.1016/j.bmcl.2015.09.004Search in Google Scholar PubMed

118. Demoin, D. W., Dame, A. N., Minard, W. D., Gallazzi, F., Seickman, G. L., Rold, T. L., Bernskoetter, N., Fassbender, M. E., Hoffman, T. J., Deakyne, C. A., Jurisson, S. S.: Monooxorhenium(V) complexes with 222-N2S2 MAMA ligands for bifunctional chelator agents: Syntheses and preliminary in vivo evaluation. Nucl. Med. Biol. 43, 802 (2016).10.1016/j.nucmedbio.2016.08.017Search in Google Scholar PubMed PubMed Central

119. Li, X., Wu, A., Xue, Q., Fang, Y., Liu, J., Zhang, H., Bao, H.: Synthesis and biological evaluation of fatty acids containing ^99mTc-oxo and ^99mTc-nitrido for myocardial metabolism imaging. J. Radioanal. Nucl. Chem. 307, 1429 (2015).10.1007/s10967-015-4232-0Search in Google Scholar

120. Ocampo-Garcia, B. E., Santos-Cuevas, C. L., De Leon-Rodriguez, L. M., Garcia-Becerra, R., Ordaz-Rosado, D., Luna-Guitierrez, M. A., Jimenez-Mancilla, N. P., Romero-Pina, M. E., Ferro-Flores, G.: Design and biological evaluation of ^99mTc-N₂S₂-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing alpha(v)beta(3) integrins. Nucl. Med. Biol. 40, 481 (2013).10.1016/j.nucmedbio.2013.01.003Search in Google Scholar PubMed

121. Rasaneh, S., Dadras, M. R.: The potential of SOCTA as a chelator for radiolabeling of trastuzumab with ^99mTc. J. Radioanal. Nucl. Chem. 307, 1353 (2015).10.1007/s10967-015-4314-zSearch in Google Scholar

122. Meszaros, L. K., Dose, A., Biagini, S. C. G., Blower, P. J.: Hydrazinonicotinic acid (HYNIC) – coordination chemistry and applications in radiopharmaceutical chemistry. Inorg. Chim. Acta 363, 1059 (2010).10.1016/j.ica.2010.01.009Search in Google Scholar

123. North, A. J., Karas, J. A., Ma, M. T., Blower, P. J., Ackermann, U., White, J. M., Donnelly, P. S.: Rhenium and technetium-oxo complexes with thioamide derivatives of pyridylhydrazine bifunctional chelators conjugated to the tumour targeting peptides octreotate and cyclic-RGDfK. Inorg. Chem. 56, 9725 (2017).10.1021/acs.inorgchem.7b01247Search in Google Scholar PubMed PubMed Central

124. Clarke, C., Cowley, A. R., Dilworth, J. R., Donnelly, P. S.: Pyridylthiocarbazide complexes of rhenium with potential radiopharmaceutical applications. Dalton Trans. 2402 (2004).10.1039/b406439aSearch in Google Scholar

125. Einrem, R. F., Braband, H., Fox, T., Vazquez-Lima, H., Alberto, R., Ghosh, A.: Synthesis and molecular structure of ⁹⁹Tc corroles. Chemistry 22, 18747 (2016).10.1002/chem.201605015Search in Google Scholar PubMed

126. Einrem, R. F., Gagnon, K. J., Alemayehu, A. B., Ghosh, A.: Metal-ligand misfits: facile access to rhenium-oxo corroles by oxidative metalation. Chemistry 22, 517 (2016).10.1002/chem.201504307Search in Google Scholar PubMed

127. Zaragoza, J. P., Siegler, M. A., Goldberg, D. P.: Rhenium(V)-oxo corrolazines: isolating redox-active ligand reactivity. Chem. Commun. (Camb.) 52, 167 (2016).10.1039/C5CC07956JSearch in Google Scholar

128. Schweyen, P., Brandhorst, K., Hoffmann, M., Wolfram, B., Zaretzke, M. K., Broring, M.: Viking helmet corroles: activating inert oxidometal corroles. Chemistry 23, 13897 (2017).10.1002/chem.201703721Search in Google Scholar PubMed

129. Zuckman, S. A., Freeman, G. M., Troutner, D. E., Volkert, W. A., Holmes, R. A., van der Veer, D. G., Barefield, E. K.: Preparation and X-ray structure of trans-Dioxo(1,4,8,11-tetraazacyclotetradecane)technetium(V) perchlorate hydrate. Inorg. Chem. 20, 2386 (1981).10.1021/ic50222a006Search in Google Scholar

130. Lock, C. J. L., Turner, G.: A Reinvestigation of dioxobis(ethylenediamine)rhenium(V) chloride and dioxotetrakis(pyridine)rhenium(V) chloride hydrate. Acta Cryst. B34, 923 (1978).10.1107/S0567740878004367Search in Google Scholar

131. Blake, A. J., Greig, J. A., Schroder, M.: Rhenium complexes of tetra-aza macrocycles: the synthesis and single-crystal X-ray structure of trans-[Re(O)₂(cyclam)]Cl·2(BPh₃·H₂O). J. Chem. Soc. Dalton Trans. 2645 (1988).10.1039/DT9880002645Search in Google Scholar

132. Nock, B. A., Charalambidis, D., Sallegger, W., Waser, B., Mansi, R., Nicolas, G. P., Ketani, E., Nikolopoulou, A., Fani, M., Reubi, J.-C., Maina, T.: New gastrin releasing peptide receptor-directed [^99mTc]demobesin 1 mimics: synthesis and comparative evaluation. J. Med. Chem. 61, 3138 (2018).10.1021/acs.jmedchem.8b00177Search in Google Scholar

133. Jurisson, S. S., Dancey, K., McPartlin, M., Tasker, P. A., Deutsch, E.: Synthesis, characterization, and electrochemical properties of technetium complexes containing both tetradentate Schiff base and monodentate tertiary phosphine ligands: single-crystal structure of trans-(N, N′-ethylenebis (acetylacetone iminato)) bis-(triphenylphosphine) technetium (III) hexafluorophosphate. Inorg. Chem. 23, 4743 (1984).10.1021/ic00194a063Search in Google Scholar

134. Bandoli, G., Mazzi, U., Wilcox, B. E., Jurisson, S., Deutsch, E.: Synthesis and characterization of technetium (V) complexes with tridentate schiff base ligands. X-ray crystal structure of chloro [N-(2-hydroxyphenyl) salicylideneiminato] oxotechnetium (V). Inorg. Chim. Acta 95, 217 (1984).10.1016/S0020-1693(00)87470-8Search in Google Scholar

135. Jurisson, S., Lindoy, L. F., Dancey, K. P., McPartlin, M., Tasker, P. A., Uppal, D. K., Deutsch, E.: New oxotechnetium (V) complexes of N, N′-ethylenebis (acetylacetone imine), N, N′-ethylenebis (salicylideneamine), and o-phenylenebis (salicylideneamine). X-ray structures of the complexes of N, N′-ethylenebis (acetylacetone imine) and N, N′-ethylenebis (salicylideneamine). Inorg. Chem. 23, 227 (1984).10.1021/ic00170a021Search in Google Scholar

136. Rossetti, C., Vanoli, G., Paganelli, G., Kwiatkowski, M., Zito, F., Colombo, F., Bonino, C., Carpinelli, A., Casati, R., Deutsch, K., Marmion, M., Woulfe, S. R., Lunghi, F., Deutsch, E., Fazio, F.: Human biodistribution, dosimetry and clinical use of technetium(III)-99m-Q12. J. Nucl. Med. 35, 1571 (1994).Search in Google Scholar

137. Marmion, M. E., Woulfe, S. R., Neumann, W., Nosco, D. L., Deutsch, E.: Preparation and characterization of technetium complexes with Schiff base and phosphine coordination. 1. Complexes of technetium-99g and-99m with substituted acac₂en and trialkyl phosphines (where acac₂en= N, N′-ethylenebis [acetylacetone iminato]). Nucl. Med. Biol. 26, 755 (1999).10.1016/S0969-8051(99)00040-2Search in Google Scholar

138. Benny, P. D., Barnes, C. L., Piekarski, P. M., Lydon, J. D., Jurisson, S. S.: Synthesis and characterization of novel rhenium(V) tetradentate N₂O₂ schiff base monomer and dimer complexes. Inorg. Chem. 42, 6519 (2003).10.1021/ic030240qSearch in Google Scholar PubMed

139. Benny, P. D., Green, J. L., Engelbrecht, H. P., Barnes, C. L., Jurisson, S. S.: Reactivity of rhenium(V) oxo schiff base complexes with phosphine ligands: rearrangement and reduction reactions. Inorg. Chem. 44, 2381 (2005).10.1021/ic048670jSearch in Google Scholar PubMed

140. Rotsch, D. A., Reinig, K. M., Weis, E. M., Taylor, A. B., Barnes, C. L., Jurisson, S. S.: Novel rhenium(III, IV, and V) tetradentate N₂O₂ Schiff base mononuclear and dinuclear complexes. Dalton Trans. 42, 11614 (2013).10.1039/c3dt51198gSearch in Google Scholar PubMed PubMed Central

141. Baumeister, J. E., Reinig, K. M., Barnes, C. L., Kelley, S. P., Jurisson, S. S.: Technetium and rhenium schiff base compounds for nuclear medicine: syntheses of rhenium analogues to ^99mTc-furifosmin. Inorg. Chem. 57, 12920 (2018).10.1021/acs.inorgchem.8b02156Search in Google Scholar PubMed

142. Spies, H., Glaser, M., Pietzsch, H.-J., Hahn, F. E., Kintzel, O., Luegger, T.: Trigonal-bipyramidal technetium and rhenium complexes with tetradentate tripodal NS₃ ligands. Angew. Chem. 106, 1416 (1994).10.1002/ange.19941061310Search in Google Scholar

143. Glaser, M., Spies, H., Lügger, T., Ekkehardt Hahn, F.: Formation of a rhenium(III) carbonyl complex by electrophilic attack on rhenium isocyanides. Synthesis and molecular structure of {Re[N(CH₂CH₂S)₃][CNC(CH₃)₃]} and {Re[N(CH₂CH₂)₃](CO)}. J. Organomet. Chem. 503, C32-C35 (1995).10.1016/0022-328X(95)05769-LSearch in Google Scholar

144. Spies, H., Glaser, M., Pietzsch, H. J., Hahn, F. E., Lugger, T.: Synthesis and reactions of trigonal-bipyramidal rhenium and technetium complexes with a tripodal, tetradentate NS₃ ligand. Inorg. Chim. Acta 240, 465 (1995).10.1016/0020-1693(95)04571-6Search in Google Scholar

145. Gniazdowska, E., Kozminski, P., Fuks, L.: Synthesis, radiochemistry and stability of the conjugates of technetium-99m complexes with substance P. J. Radioanal. Nucl. Chem. 298, 1171 (2013).10.1007/s10967-013-2526-7Search in Google Scholar

146. Gniazdowska, E., Kozminski, P., Bankowski, K., Luniewski, W., Krolicki, L.: Synthesis, physicochemical and biological evaluation of technetium-99m labeled lapatinib as a novel potential tumor imaging agent of HER-2 positive breast cancer. Eur. J. Med. Chem. 87, 493 (2014).10.1016/j.ejmech.2014.09.080Search in Google Scholar PubMed

147. Gniazdowska, E., Kozminski, P., Bankowski, K., Ochman, P.: ^99mTc-labeled vasopressin peptide as a radiopharmaceutical for small-cell lung cancer (SCLC) diagnosis. J. Med. Chem. 57, 5986 (2014).10.1021/jm500272rSearch in Google Scholar PubMed

148. Kozminski, P., Gniazdowska, E.: Synthesis and in vitro/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals. Nucl. Med. Biol. 42, 28 (2015).10.1016/j.nucmedbio.2014.08.012Search in Google Scholar PubMed

149. Sakhare, N., Das, S., Mathur, A., Mirapurkar, S., Paradkar, S., Sarma, H. D., Sachdev, S. S.: Synthesis and characterization of a novel ^99mTc analogue of *I-mIBG showing affinity for nor-epinephrine transport positive tumors. RSC Adv. 6, 64902 (2016).10.1039/C6RA11217JSearch in Google Scholar

150. Vats, K., Mallia, M. B., Mathur, A., Sarma, H. D., Banerjee, S.: ‘4+1’ mixed ligand strategy for the preparation of ^99mTc-radiopharmaceuticals for hypoxia detecting applications. ChemistrySelect 2, 2910 (2017).10.1002/slct.201700150Search in Google Scholar

151. Gniazdowska, E., Kozminski, P., Wasek, M., Bajda, M., Sikora, J., Mikiciuk-Olasik, E., Szymanski, P.: Synthesis, physicochemical and biological studies of technetium-99m labeled tacrine derivative as a diagnostic tool for evaluation of cholinesterase level. Bioorg. Med. Chem. 25, 912 (2017).10.1016/j.bmc.2016.12.004Search in Google Scholar PubMed

152. Seifert, S., Kunstler, J. U., Schiller, E., Pietzsch, H. J., Pawelke, B., Bergmann, R., Spies, H.: Novel procedures for preparing ^99mTc(III) complexes with tetradentate/monodentate coordination of varying lipophilicity and adaptation to ¹⁸⁸Re analogues. Bioconjugate Chem. 15, 856 (2004).10.1021/bc0300798Search in Google Scholar PubMed

153. Schiller, E., Seifert, S., Tisato, F., Refosco, F., Kraus, W., Spies, H., Pietzsch, H.-J.: Mixed-ligand rhenium-188 complexes with tetradentate/monodentate NS₃/P (‘4+1’) coordination: relation of structure with antioxidation stability. Bioconjugate Chem. 16, 634 (2005).10.1021/bc049745aSearch in Google Scholar PubMed

154. Kunstler, J. U., Bergmann, R., Gniazdowska, E., Kozminski, P., Walther, M., Pietzsch, H. J.: Impact of functionalized coligands on the pharmacokinetics of ^99mTc(III) ‘4+1’ mixed-ligand complexes conjugated to bombesin. J. Inorg. Biochem. 105, 1383 (2011).10.1016/j.jinorgbio.2011.07.002Search in Google Scholar PubMed

155. Alberto, R., Schibli, R., Egli, A., Schubiger, A. P., Abram, U., Kaden, T. A.: A novel organometallic aqua complex of technetium for the labeling of biomolecules: synthesis of [^99mTc(OH₂)₃(CO)₃]⁺ from [^99mTcO₄]⁻ in aqueous solution and its reaction with a bifunctional ligand. J. Am. Chem. Soc. 120, 7987 (1998).10.1021/ja980745tSearch in Google Scholar

156. Schibli, R., La Bella, R., Alberto, R., Garcia-Garayoa, E., Ortner, K., Abram, U., Schubiger, P. J. B. C.: Influence of the denticity of ligand systems on the in vitro and in vivo behavior of ^99mTc(I)−tricarbonyl complexes: a hint for the future functionalization of biomolecules. Bioconjugate Chem. 11, 345 (2000).10.1021/bc990127hSearch in Google Scholar PubMed

157. Kluba, C. A., Mindt, T. L.: Click-to-Chelate: development of technetium and rhenium-tricarbonyl labeled radiopharmaceuticals. Molecules 18, 3206 (2013).10.3390/molecules18033206Search in Google Scholar PubMed PubMed Central

158. Mindt, T., Struthers, H., Garcia-Garayoa, E., Desbouis, D., Schibli, R.: Strategies for the development of novel tumor targeting technetium and rhenium radiopharmaceuticals. Chimia 61, 725 (2007).10.2533/chimia.2007.725Search in Google Scholar

159. Camacho, X., García, M. F., Calzada, V., Fernández, M., Chabalgoity, J. A., Moreno, M., De Aguiar, R. B., Alonso, O., Gambini, J. P., Chammas, R.: [^99mTc(CO)₃]⁺ Radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma model. Oncology 84, 200 (2013).10.1159/000338961Search in Google Scholar PubMed

160. Chen, W.-J., Yen, C.-L., Lo, S.-T., Chen, K.-T., Lo, J.-M.: Direct 99mTc labeling of Herceptin (trastuzumab) by ^99mTc(I) tricarbonyl ion. Appl. Radiat. Isot. 66, 340 (2008).10.1016/j.apradiso.2007.09.007Search in Google Scholar PubMed

161. Pandey, U., Kameswaran, M., Sarma, H. D., Samuel, G.: ^99mTc carbonyl DTPA–rituximab: preparation and preliminary bioevaluation. Appl. Radiat. Isot. 86, 52 (2014).10.1016/j.apradiso.2013.12.036Search in Google Scholar PubMed

162. Stopar, T. G., Mlinaric-Rascan, I., Fettich, J., Hojker, S., Mather, S.: ^99mTc-rituximab radiolabelled by photo-activation: a new non-Hodgkin’s lymphoma imaging agent. Eur. J. Nucl. Med. Mol. Imaging 33, 53 (2006).10.1007/s00259-005-1838-4Search in Google Scholar PubMed

163. Egli, A., Alberto, R., Tannahill, L., Schibli, R., Abram, U., Schaffland, A., Waibel, R., Tourwé, D., Jeannin, L., Iterbeke, K.: Organometallic ^99mTc-aquaion labels peptide to an unprecedented high specific activity. J. Nucl. Med. 40, 1913 (1999).Search in Google Scholar

164. Meares, C. F., Moi, M. K., Diril, H., Kukis, D. L., McCall, M. J., Deshpande, S. V., DeNardo, S. J., Snook, D., Epenetos, A. A.: Macrocyclic chelates of radiometals for diagnosis and therapy. Br. J. Cancer Suppl. 10, 21 (1990).Search in Google Scholar

165. Carpenet, H., Cuvillier, A., Monteil, J., Quelven, I.: Anti-CD20 Immunoglobulin G radiolabeling with a ^99mTc-tricarbonyl core: in vitro and in vivo evaluations. PLoS One 10, e0139835 (2015).10.1371/journal.pone.0139835Search in Google Scholar PubMed PubMed Central

166. Biechlin, M. L., d’Hardemare, A. d. M., Fraysse, M., Gilly, F. N., Bonmartin, A.: Improvement in radiolabelling proteins with the ^99mTc-tricarbonyl-core [^99mTc(CO)₃]⁺, by thiol-derivatization with iminothiolane: application to γ-globulins and annexin V. J. Label. Compd. Radiopharm. 48, 873 (2005).10.1002/jlcr.999Search in Google Scholar

167. Ellis, B. L., Gorshkov, N. I., Lumpov, A. A., Miroslavov, A. E., Yalfimov, A. N., Gurzhiy, V. V., Suglobov, D. N., Braddock, R., Adams, J. C., Smith, A.-M., Prescott, M. C., Sharma, H. L.: Synthesis, characterization and pre-clinical evaluation of ^99mTc-tricarbonyl complexes as potential myocardial perfusion imaging agents. J. Label. Compd. Radiopharm. 56, 700 (2013).10.1002/jlcr.3106Search in Google Scholar PubMed

168. Pitchumony, T. S., Banevicius, L., Janzen, N., Zubieta, J., Valliant, J. F.: Isostructural nuclear and luminescent probes derived from [2+1] rhenium(I)/technetium(I) organometallic complexes. Inorg. Chem. 52, 13521 (2013).10.1021/ic401972gSearch in Google Scholar PubMed

169. Hayes, T. R., Bottorff, S. C., Slocumb, W. S., Barnes, C. L., Clark, A. E., Benny, P. D.: Influence of bidentate ligand donor types on the formation and stability in 2 + 1 fac-[M^I(CO)₃]⁺ (M=Re, ^99mTc) complexes. Dalton Trans. 46, 1134 (2017).10.1039/C6DT04282ASearch in Google Scholar PubMed PubMed Central

170. Connell, T. U., Hayne, D. J., Ackermann, U., Tochon-Danguy, H. J., White, J. M., Donnelly, P. S.: Rhenium and technetium tricarbonyl complexes of 1,4-Substituted pyridyl-1,2,3-triazole bidentate ‘click’ ligands conjugated to a targeting RDG peptide. J. Label. Compd. Radiopharm. 57, 262 (2014).10.1002/jlcr.3169Search in Google Scholar PubMed

171. North, A. J., Hayne, D. J., Schieber, C., Price, K., White, A. R., Crouch, P. J., Rigopoulos, A., O’Keefe, G. J., Tochon-Danguy, H., Scott, A. M., White, J. M., Ackermann, U., Donnelly, P. S.: Toward hypoxia-selective rhenium and technetium tricarbonyl complexes. Inorg. Chem. 54, 9594 (2015).10.1021/acs.inorgchem.5b01691Search in Google Scholar PubMed

172. Hayes, T. R., Lyon, P. A., Barnes, C. L., Trabue, S., Benny, P. D.: Influence of functionalized pyridine ligands on the radio/chemical behavior of [M^I(CO)₃]⁺ (M=Re and ^99mTc) 2 + 1 complexes. Inorg. Chem. 54, 1528 (2015).10.1021/ic502520xSearch in Google Scholar PubMed

173. Chan, C. Y., Pellegrini, P. A., Greguric, I., Barnard, P. J.: Rhenium and technetium tricarbonyl complexes of N-heterocyclic carbene ligands. Inorg. Chem. 53, 10862 (2014).10.1021/ic500917sSearch in Google Scholar PubMed

174. Shegani, A., Triantis, C., Nock, B. A., Maina, T., Kiritsis, C., Psycharis, V., Raptopoulou, C., Pirmettis, I., Tisato, F., Papadopoulos, M. S.: Rhenium(I) tricarbonyl complexes with (2-hydroxyphenyl)diphenylphosphine as PO bidentate ligand. Inorg. Chem. 56, 8175 (2017).10.1021/acs.inorgchem.7b00894Search in Google Scholar PubMed

175. Mundwiler, S., Kündig, M., Ortner, K., Alberto, R.: A new [2 + 1] mixed ligand concept based on [^99(m)Tc(OH₂)₃(CO)₃]⁺: a basic study. Dalton Trans. 1320 (2004).10.1039/B400220BSearch in Google Scholar

176. Kolb, H. C., Finn, M., Sharpless, K. B.: Click chemistry: diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. 40, 2004 (2001).10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5Search in Google Scholar

177. Diez-Gonzalez, S., Marion, N., Nolan, S. P.: N-heterocyclic carbenes in late transition metal catalysis. Chem. Rev. 109, 3612 (2009).10.1021/cr900074mSearch in Google Scholar

178. Díez-González, S., Nolan, S. P.: Stereoelectronic parameters associated with N-heterocyclic carbene (NHC) ligands: a quest for understanding. Coord. Chem. Rev. 251, 874 (2007).10.1016/j.ccr.2006.10.004Search in Google Scholar

179. Schibli, R., Schubiger, A. P.: Current use and future potential of organometallic radiopharmaceuticals. Eur. J. Nucl. Med. Mol. Imaging 29, 1529 (2002).10.1007/s00259-002-0900-8Search in Google Scholar

180. Bolzati, C., Tisato, F., Refosco, F., Bandoli, G., Dolmella, A.: Uncommon anionic dioxorhenium(V) and neutral monooxorhenium(V) mixed-ligand complexes containing heterofunctionalized phosphine ligands: syntheses and structural characterization. Inorg. Chem. 35, 6221 (1996).10.1021/ic960404lSearch in Google Scholar

181. Nock, B., Maina, T., Tisato, F., Raptopoulou, C. P., Terzis, A., Chiotellis, E.: Oxorhenium phosphinophenolato complexes with model peptide fragments: synthesis, characterization, and stability considerations. Inorg. Chem. 39, 5197 (2000).10.1021/ic000154fSearch in Google Scholar

182. Nock, B., Maina, T., Tisato, F., Papadopoulos, M., Raptopoulou, C. P., Terzis, A., Chiotellis, E.: Novel six-coordinate oxorhenium “3 + 2” mixed-ligand complexes carrying the SNS/PO donor atom set: synthesis and characterization. Inorg. Chem. 38, 4197 (1999).10.1021/ic9905796Search in Google Scholar

183. Morais, M., Paulo, A., Gano, L., Santos, I., Correia, J. D. G.: Target-specific Tc(CO)₃^+_complexes for in vivo imaging. J. Organomet. Chem. 744, 125 (2013).10.1016/j.jorganchem.2013.05.050Search in Google Scholar

184. Morais, G. R., Paulo, A., Santos, I.: Organometallic complexes for SPECT imaging and/or radionuclide therapy. Organometallics 31, 5693 (2012).10.1021/om300501dSearch in Google Scholar

185. Correia, J. D., Paulo, A., Santos, I.: Re and Tc complexes with pyrazolyl-containing chelators: from coordination chemistry to target-specific delivery of radioactivity. Curr. Radiopharm. 2, 277 (2009).10.2174/1874471010902040277Search in Google Scholar

186. Alberto, R.: Organometallic Radiopharmaceuticals. In: Medicinal Organometallic Chemistry, Springer (2010), p. 219.10.1007/978-3-642-13185-1_9Search in Google Scholar

187. Papagiannopoulou, D., Makris, G., Tsoukalas, C., Raptopoulou, C. P., Terzis, A., Pelecanou, M., Pirmettis, I., Papadopoulos, M. S.: Rhenium (I) and technetium (I) fac-M (NSO)(CO)₃ (M= Re, ^99mTc) tricarbonyl complexes, with a tridentate NSO bifunctional agent: synthesis, structural characterization, and radiochemistry. Polyhedron 29, 876 (2010).10.1016/j.poly.2009.10.009Search in Google Scholar

188. Makris, G., Radford, L., Gallazzi, F., Jurisson, S., Hennkens, H., Papagiannopoulou, D.: Synthesis and evaluation of fac-[^99mTc/Re(CO)₃]⁺ complexes with a new (N, S, N) bifunctional chelating agent: the first example of a fac-[Re(CO)₃(N,S,N-sst₂-ANT)] complex bearing a somatostatin receptor antagonist peptide. J. Organomet. Chem. 805, 100 (2016).10.1016/j.jorganchem.2016.01.005Search in Google Scholar

189. Radford, L., Gallazzi, F., Watkinson, L., Carmack, T., Berendzen, A., Lewis, M. R., Jurisson, S. S., Papagiannopoulou, D., Hennkens, H. M.: Synthesis and evaluation of a Tc-99m tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors. Nucl. Med. Biol. 47, 4 (2017).10.1016/j.nucmedbio.2016.12.002Search in Google Scholar PubMed

190. Nunes, P., Morais, G. R., Palma, E., Silva, F., Oliveira, M. C., Ferreira, V. F., Mendes, F., Gano, L., Miranda, H. V., Outeiro, T. F.: Isostructural Re(I)/^99mTc(I) tricarbonyl complexes for cancer theranostics. Org. Biomol. Chem. 13, 5182 (2015).10.1039/C5OB00124BSearch in Google Scholar PubMed

191. Giglio, J., Dematteis, S., Fernandez, S., Cerecetto, H., Rey, A.: Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent. J. Label. Compd. Radiopharm. 57, 403 (2014).10.1002/jlcr.3195Search in Google Scholar PubMed

192. Hillier, S. M., Maresca, K. P., Lu, G., Merkin, R. D., Marquis, J. C., Zimmerman, C. N., Eckelman, W. C., Joyal, J. L., Babich, J. W.: ^99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer. J. Nucl. Med. 54, 1369 (2013).10.2967/jnumed.112.116624Search in Google Scholar PubMed

193. Vallabhajosula, S., Nikolopoulou, A., Babich, J. W., Osborne, J. R., Tagawa, S. T., Lipai, I., Solnes, L., Maresca, K. P., Armor, T., Joyal, J. L.: ^99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer. J. Nucl. Med. 55, 1791 (2014).10.2967/jnumed.114.140426Search in Google Scholar PubMed

194. Liu, T., Gan, Q., Zhang, J.: Macrocyclic triamine derived glucose analogues for ^99mTc(CO)₃ labeling: synthesis and biological evaluation as potential tumor-imaging agents. Chem. Biol. Drug. Des. 89, 277 (2017).10.1111/cbdd.12784Search in Google Scholar PubMed

195. Duan, X., Liu, T., Zhang, Y., Zhang, J.: Synthesis and biological evaluation of novel ^99mTc(CO)₃-labeled thymidine analogs as potential probes for tumor proliferation imaging. Molecules 21, 510 (2016).10.3390/molecules21040510Search in Google Scholar

196. Makris, G., Radford, L. L., Kuchuk, M., Gallazzi, F., Jurisson, S. S., Smith, C. J., Hennkens, H. M.: NOTA and NODAGA [^99mTc]Tc- and [¹⁸⁶Re]Re-tricarbonyl complexes: radiochemistry and first example of a [^99mTc]Tc-NODAGA somatostatin receptor-targeting bioconjugate. Bioconjugate Chem. 29, 4040 (2018).10.1021/acs.bioconjchem.8b00670Search in Google Scholar

197. Frei, A., Spingler, B., Alberto, R.: Multifunctional cyclopentadiene as a scaffold for combinatorial bioorganometallics in [(η⁵-C₅H₂R₁R₂R₃)M(CO)₃] (M=Re, ^99mTc) piano-stool type complexes. Chem. Eur. J. 24, 10156 (2018).10.1002/chem.201801271Search in Google Scholar

198. Hatanaka, M., Tanaka, Y., Himeda, Y., Ueda, I.: A single-step synthesis of 4-hydroxycyclopentenones from 3-ethoxycarbonyl-2-oxo-propylidenetriphenylphosphorane and glyoxals. Tetrahedron Lett. 34, 4837 (1993).10.1016/S0040-4039(00)74103-7Search in Google Scholar

199. Jia, J., Cui, M., Kai, J. Liu, B.: 2-Phenylbenzothiazole conjugated with cyclopentadienyl tricarbonyl [CpM(CO)₃] (M=Re, ^99mTc) complexes as potential imaging probes for β-amyloid plaques. Dalton Trans. 44, 6406 (2015).10.1039/C5DT00023HSearch in Google Scholar

200. Li, X., Chen, S., Liu, Z., Zhao, Z., Lu, J.: Syntheses and evaluations of the methoxy modified ^99mTc-labeled triphenyl phosphonium cations: Potential radiometallic probes for multidrug resistance detection. J. Organomet. Chem. 871, 28 (2018).10.1016/j.jorganchem.2018.07.003Search in Google Scholar

201. Benz, M., Braband, H., Schmutz, P., Halter, J., Alberto, R.: From Tc(VII) to Tc(I); facile syntheses of bis-arene complexes [^99mTc(arene)₂]⁺ from pertechnetate. Chem. Sci. 6, 165 (2015).10.1039/C4SC02461CSearch in Google Scholar

202. Meola, G., Braband, H., Schmutz, P., Benz, M., Spingler, B., Alberto, R.: Bis-arene complexes [Re(η⁶-arene)₂]⁺ as highly stable bioorganometallic scaffolds. Inorg. Chem. 55, 11131 (2016).10.1021/acs.inorgchem.6b01748Search in Google Scholar PubMed

203. Meola, G., Braband, H., Jordi, S., Fox, T., Blacque, O., Spingler, B., Alberto, R.: Structure and reactivities of rhenium and technetium bis-arene sandwich complexes [M(η⁶-arene)₂]⁺. Dalton Trans. 46, 14631 (2017).10.1039/C7DT02072DSearch in Google Scholar

204. Meola, G., Braband, H., Hernandez-Valdes, D., Gotzmann, C., Fox, T., Spingler, B., Alberto, R.: A mixed-ring sandwich complex from unexpected ring contraction in [Re(η⁶-C₆H₅Br)(η⁶-C₆R₆)](PF₆). Inorg. Chem. 56, 6297 (2017).10.1021/acs.inorgchem.7b00394Search in Google Scholar PubMed

205. Hernández-Valdés, D., Meola, G., Braband, H., Spingler, B., Alberto, R.: Direct Synthesis of non-alkyl functionalized bis-arene complexes of rhenium and ^99(m)technetium. Organometallics 37, 2910 (2018).10.1021/acs.organomet.8b00494Search in Google Scholar

206. DeGraffenreid, A. J., Feng, Y., Wycoff, D. E., Morrow, R., Phipps, M. D., Cutler, C. S., Ketring, A. R., Barnes, C. L., Jurisson, S. S.: Dithiol aryl arsenic compounds as potential diagnostic and therapeutic radiopharmaceuticals. Inorg. Chem. 55, 8091 (2016).10.1021/acs.inorgchem.6b01175Search in Google Scholar PubMed

207. DeGraffenreid, A. J., Feng, Y., Barnes, C. L., Ketring, A. R., Cutler, C. S., Jurisson, S. S.: Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals. Nucl. Med. Biol. 43, 288 (2016).10.1016/j.nucmedbio.2016.01.005Search in Google Scholar PubMed PubMed Central

208. Ellison, P. A., Barnhart, T. E., Chen, F., Hong, H., Zhang, Y., Theuer, C. P., Cai, W., Nickles, R. J., DeJesus, O. T.: High yield production and radiochemical isolation of isotopically pure arsenic-72 and novel radioarsenic labeling strategies for the development of theranostic radiopharmaceuticals. Bioconjugate Chem. 27, 179 (2016).10.1021/acs.bioconjchem.5b00592Search in Google Scholar PubMed PubMed Central

209. Feng, Y., DeGraffenreid, A. J., Phipps, M. D., Rold, T. L., Okoye, N. C., Gallazzi, F. A., Barnes, C. L., Cutler, C. S., Ketring, A. R., Hoffman, T. J., Jurisson, S. S.: A trithiol bifunctional chelate for ^72,77As: A matched pair theranostic complex with high in vivo stability. Nucl. Med. Biol. 61, 1 (2018).10.1016/j.nucmedbio.2018.03.001Search in Google Scholar PubMed

210. Jahn, M., Radchenko, V., Filosofov, D., Hauser, H., Eisenhut, M., Rosch, F., Jennewein, M.: Separation and purification of no-carrier-added arsenic from bulk amounts of germanium for use in radiopharmaceutical labelling. Radiochim. Acta 98, 807 (2010).10.1524/ract.2010.1783Search in Google Scholar